Internet | Biotech Stock Review | News On Internet and Biotech Stocks. | Page 91

Internet News

Intelity a Hotel Communication Network Raises $44 Million.

Editor / Curator - February 28, 2019

All News

Data Brokers, Prying Eyes!

Editor / Curator - February 28, 2019

revelers.io

All News

Low Carbs and AFIB?

Editor / Curator - February 27, 2019

All News

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application...

Editor / Curator - February 26, 2019

biotech stock review

All News

Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.

Editor / Curator - February 21, 2019

Video

NanoVibronix (NAOV) CEO Brian Murphy on Fox News.

Editor / Curator - February 13, 2019

Internet News

Galaxy Next Generation (GAXY) Commitment of $600,000 From a Single...

Editor / Curator - February 6, 2019

nanovibronix, biotech stock review

Research

NanoVibronix (NAOV) $3.35, Gets $10.50 Price target from Dawson James.

Editor / Curator - January 9, 2019

Dr. Lindsay Rosenwald

Biotech News

Dr Lindsay Rosenwald, Biography.

Editor / Curator - January 4, 2019

Internet Stock Review

Research

Model Portfolio

Editor / Curator - January 1, 2019

1...909192...94 Page 91 of 94

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator - April 18, 2025

Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator - April 15, 2025

Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator - April 14, 2025

LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062